TITLE

Prevalence of Hepatitis C Virus Infection in Different Population Groups in Southern Italy

AUTHOR(S)
Montella, M.; Crispo, A.; Grimaldi, M.; Angeletti, C.; Amore, A.; Ronga, D.; Sabbatici, M.; Pisani, A.; Spiteri, D.; Serraino, D.
PUB. DATE
February 2005
SOURCE
Infection;Feb2005, Vol. 33 Issue 1, p9
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: A cross-sectional. investigation was carried out between 2000 and 2002 to assess the prevalence of hepatitis C virus infection (HCV) in Naples, southern Italy. Patients and Methods: Five groups of individuals were investigated, two at low risk and three at high risk for HCV infection. Blood sample sera were collected among 5,391 individuals (4,059 men and 1,332 women): 1,972 general. practitioner (GP) patients and 781 employees of the National. Cancer Institute (NCI) of Naples (low-risk groups); 524 male prisoners, 1,436 intravenous drug users (IDUs) and 678 hemodialysis patients (high-risk groups). Results: Overall HCV seropositivity rates ranged from 6.4% among employees of the NCI to 37.4% among male prisoners. HCV infection tended to generally increase with age, but in IDUs and in male prisoners the upward trend leveled off at 50 years of age. As compared to GP patients, IDUs (both sexes) and male prisoners had a nearly 6-fold increased risk of HCV infection, while HCV was nearly 3-fold more common among hemodialysis patients. Employees of NCI were at reduced risk of HCV infection, particularly women (odds ratio = 0.3). Conclusion: The study findings confirmed the high risk for HCV infection in IDUs and identified other population groups in southern Italy that should be offered HCV screening and counselling given the severe implications of HCV infection on health.
ACCESSION #
16311970

 

Related Articles

  • When can a risk factor be used as a worthwhile screening test? Wald, NJ; Hackshaw, A. K. // BMJ: British Medical Journal (International Edition);12/11/99, Vol. 319 Issue 7224, p1562 

    Presents a study which specified the quantitative relation between risk factors and screening tests. Association of a strong risk factor with a disease before it is likely to be a useful screening test; Methodology of the study; Results and discussion; Conclusions.

  • ADMA accumulation may be risk factor for cardiovascular disease in chronic renal failure. Zoccali, C.; Bode-Boger, S. M. // Kidney;Jul/Aug2002, Vol. 11 Issue 4, p164 

    Deals with a study which investigated the relation between cardiovascular risk factors and plasma asymmetrical dimethyl-argenine (ADMA) concentration in a cohort of hemodialysis patients and to test the predictive power of ADMA for mortality and cardiovascular outcomes. Methodology used in the...

  • Treatment of Occult Hepatitis C Virus Infection: Does It Need Special Attention? Rezaee-Zavareh, Mohammad Saeid; Einollahi, Behzad // Hepatitis Monthly;Jul2014, Vol. 14 Issue 7, p1 

    A letter to the editor is presented in response of the article "Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013" by N. Ebrahimi Daryani, S. M. Alavian and colleagues, published in 2013 issue.

  • Early diagnosis of interferon-induced myocardial disorder in patients with chronic hepatitis C: evaluation by myocardial imaging with 123I-BMIPP. Kondo, Yuki; Yukinaka, Michiko; Nomura, Masahiro; Nakaya, Yutaka; Ito, Susumu; Kondo, Y; Yukinaka, M; Nomura, M; Nakaya, Y; Ito, S // Journal of Gastroenterology;2000, Vol. 35 Issue 2, p127 

    Interferon (IFN) therapy for chronic hepatitis C is sometimes associated with cardiac complications. In the present study, we performed myocardial imaging with 123I-labeled beta-methyl-p-iodophenylpentadecanoic acid (123I-BMIPP) in order to evaluate myocardial disorders caused by IFN. We studied...

  • New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets. Ploss, Alexander; Dubuisson, Jean // Gut;May2012 Supplement 1, Vol. 61, pi25 

    Hepatitis C virus (HCV) causes chronic infection in almost 2% of the world's population. If untreated, chronic carriers can develop severe liver disease including fibrosis, cirrhosis and hepatocellular carcinoma. Until recently, hepatitis C was treated with a combination of pegylated interferon...

  • Hepatitis C in India. Mukhopadhya, Ashis // Journal of Biosciences;Nov2008, Vol. 33 Issue 4, p465 

    Hepatitis C is an emerging infection in India and an important pathogen causing liver disease in India. The high risk of chronicity of this blood-borne infection and its association with hepatocellular carcinoma underscores its public health importance. Blood transfusion and unsafe therapeutic...

  • Pharmacotherapy of Hepatitis C Virus Infection: A Brief Review. Quan, David J. // Nephrology Nursing Journal;May/Jun2009, Vol. 36 Issue 3, p333 

    Infection with the hepatitis C virus is a major public health problem and is the leading cause of liver disease in the United States. Chronic infection with hepatitis C virus can lead to liver disease, cirrhosis, and hepatocellular carcinoma. Treatment options include interferon or...

  • Glucose Abnormalities Are an Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C. Lecube, Albert; Hernández, Cristina; Simó, Rafael; Esteban, Juan Ignacio; Genescà, Joan // American Journal of Gastroenterology;Oct2007, Vol. 102 Issue 10, p2189 

    OBJECTIVES: The influence of glucose abnormalities on the efficacy of antiviral treatment is unknown. This study investigated whether glucose abnormalities (impaired fasting glucose and type 2 diabetes) influence the response to antiviral therapy with interferon plus ribavirin in patients with...

  • Iatrogenic Transmission of Human T Cell Lymphotropic Virus Type 1 and Hepatitis C Virus through Parenteral Treatment and Chemoprophylaxis of Sleeping Sickness in Colonial Equatorial Africa. Pépinz, Jacques; Labbé, Annie-Claude; Mamadou-Yaya, Fleurie; Mbélesso, Pascal; Mbadingaï, Sylvestre; Deslandes, Sylvie; Locas, Marie-Claude; Frost, Eric // Clinical Infectious Diseases;10/1/2010, Vol. 51 Issue 7, p777 

    Background. The simultaneous emergence of human immunodeficiency virus (HIV)-1 group M and HIV-2 into human populations, circa 1921-1940, is attributed to urbanization and changes in sexual behavior. We hypothesized that the initial dissemination of HIV-1, before sexual transmission...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics